Markman, M <br/><br/>
Carboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer?  [electronic resource] 

 -  Journal of cancer research and clinical oncology  1996 
 - 443-4 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/BF01187154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carboplatin--therapeutic use<br/>Cisplatin--therapeutic use<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy